AMSBIO has announced a new on-demand webinar entitled 'CometAssay: Detecting single and double strand DNA breaks in individual cells'. Presented by Dr Sandra Woodgate, a Subject Matter Expert for this technique., this informative webinar explores how the Comet Assay quantitates DNA damage and repair from in vivo and in vitro samples of eukaryotic cells.
The comet assay or single cell gel electrophoresis (SCGE) is a technique to easily and rapidly detect and quantitate DNA fragmentation associated with DNA damage caused by apoptosis and cytotoxicity. The technique can be particularly useful in the field of genotoxicity testing, human biomonitoring, cellular response to DNA damage, and for screening cancer therapeutics.
In this recorded webinar, Dr Woodgate provides an informative introduction to the Comet Assay, how it works and how standardized CometAssay technology offers a unique system for reproducibly measuring DNA damage. Further the webinar includes real application data, demonstrating the use of CometAssay techniques for studying cellular response to DNA damage, as well as to screen inhibitors to DNA repair, test chemicals for toxicity and screen samples for environmental mutagens.
To view the webinar please visit www.amsbio.com/cometassay-webinar.aspx. For further information on CometAssay please visit http://www.amsbio.com/Comet-Assays.aspx or contact AMSBIO now on +44-1235-828200 / +1-949-768-8365 or email email@example.com
Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology products and services for research and development in the medical, nutrition, cosmetics and energy industries. The AMSBIO range includes specialist antibodies, peptides and recombinant proteins. In addition the company is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as experts in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance screening outcomes and eventual prognosis. With a range of molecular detection reagents, and a significant Biorepository the company can also provide tissue DNA, RNA, protein and microarray products. Key research areas for these products include: Oncology, Regenerative Medicine, Environmental Analysis, Cytotoxicity Screening, Glycomics and Stem Cell Biology.
AMS Biotechnology (AMSBIO)
184 Milton Park
Oxon OX14 4SE
North American HQ AMSBIO LLC
23591 El Toro Road, Suite#180
Lake Forest, CA 92630